Conference Call Scheduled for Tuesday, June 30 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specia

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026

07:00am, Tuesday, 23'rd Jun 2026

Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026 Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Eli

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

07:00am, Monday, 15'th Jun 2026

Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufact

Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product

07:00am, Monday, 01'st Jun 2026

Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufactu

Critical Comparison: Elite Pharmaceuticals (OTCMKTS:ELTP) versus Rafael (NYSE:RFL)

02:15am, Wednesday, 08'th Apr 2026

Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses

Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?

04:57am, Tuesday, 07'th Apr 2026

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.40 and trad

Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets

08:00am, Thursday, 02'nd Apr 2026

Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,

Elite Pharmaceuticals (OTCMKTS:ELTP) Shares Cross Below 200-Day Moving Average – Should You Sell?

02:52am, Saturday, 28'th Mar 2026

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shares passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.52 and

Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump

12:01pm, Friday, 20'th Feb 2026

ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.

Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript

07:14pm, Wednesday, 18'th Feb 2026

Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information

04:18pm, Tuesday, 17'th Feb 2026

Conference Call Scheduled for Wednesday, February 18 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026

04:30pm, Wednesday, 11'th Feb 2026

Financials for Third Quarter of Fiscal Year 2026 Ended December 31, 2025 will be released on Tuesday, February 17, 2026 Northvale, New Jersey--(Newsfile Corp. - February 11, 2026) - Elite Pharmaceutic

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by